(1-甲基-4-二环[2.2.2]辛基)甲醇 | 28305-83-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: (1-甲基-4-二环[2.2.2]辛基)甲醇
• 英文名称: 4-methylbicyclo<2.2.2>octane-1-methanol
• 英文别名: 1-(hydroxymethyl)-4-methylbicyclo[2.2.2]octane；1-Hydroxymethyl-4-methyl-bicyclo<2.2.2>octan；1-Methyl-4-hydroxymethyl-bicyclo<2.2.2>octan；4-Methylbicyclo<2.2.2>octan-1-methanol；4-Methylbicyclo[2.2.2]octan-1-methanol；(4-Methylbicyclo[2.2.2]octan-1-yl)methanol；(4-methyl-1-bicyclo[2.2.2]octanyl)methanol
• CAS: 28305-83-1
• 化学式: C₁₀H₁₈O
• 分子量: 154.252
• InChiKey: UDNIMRNTWHDLKM-UHFFFAOYSA-N

物化性质

• 沸点：
  130 °C(Press: 4.5 Torr)
• 密度：
  1.021±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  (1-甲基-4-二环[2.2.2]辛基)甲醇 在 吡啶 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 4-methylbicyclo(2.2.2)octylmethyl 4-cyanophenyl ether
  参考文献：
  名称：

  Carr, N.; Gray, G. W., Molecular Crystals and Liquid Crystals (1969-1991), 1985, vol. 124, p. 27 - 44

  摘要：

  DOI：
• 作为产物：
  描述：

  1-甲氧基-4-甲基-双环[2.2.2]辛烷 在 dimethyl sulfide borane 、 氢碘酸 、 叔丁基锂 、 乙酸酐 作用下， 以 四氢呋喃 为溶剂， 反应 20.25h， 生成 (1-甲基-4-二环[2.2.2]辛基)甲醇
  参考文献：
  名称：

  Polar substituent effects on fluorine-19 chemical shifts of aryl and vinyl fluorides: a fluorine-19 nuclear magnetic resonance study of some 1,1-difluoro-2-(4-substituted-bicyclo[2.2.2]oct-1-yl)ethenes

  摘要：

  DOI：

  10.1021/jo00207a033

文献信息

• [EN] SYNTHESIS OF BICYCLO[2.2.2]OCTANE DERIVATIVES<br/>[FR] SYNTHÈSE DE DÉRIVÉS DE BICYCLO[2.2.2]OCTANE
  申请人：EASTMAN CHEM CO

  公开号：WO2019075004A1

  公开（公告）日：2019-04-18

  Provided is a process for the preparation of certain 1,4-bicyclo[2.2.2]octane derivatives. The new synthetic procedure involves treating 1,4-dimethylene cyclohexane with an oxidizing agent in the presence of a transition metal catalyst to afford an oxo-substituted bicyclo[2.2.2]octane species. This intermediate structure can then be further derivatized. The processes of this disclosure thus affords a novel and simplified means for the commercial production of a wide variety of bicyclo[2.2.2]octane derivatives.

  提供了一种制备特定1,4-双环[2.2.2]辛烷衍生物的过程。这种新的合成方法涉及将1,4-二亚甲基环己烷与氧化剂在过渡金属催化剂存在下处理，以得到一个氧代取代的双环[2.2.2]辛烷物种。然后可以进一步对这种中间结构进行衍生化。因此，本公开的方法为商业生产各种双环[2.2.2]辛烷衍生物提供了一种新颖且简化的手段。
• [EN] BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS<br/>[FR] COMPOSÉS BICYCLIQUES PONTÉS POUR LE TRAITEMENT DES INFECTIONS BACTÉRIENNES
  申请人：KYORIN SEIYAKU KK

  公开号：WO2013003383A1

  公开（公告）日：2013-01-03

  Novel bridged bicyclic compounds are disclosed herein, along with their pharmaceutically acceptable salts, hydrates and prodrugs. Also disclosed are compositions comprising such compounds, methods of preparing such compounds and methods of using such compounds as antibacterial agents. The disclosed compounds, their pharmaceutically acceptable salts, hydrates and prodrugs, as well as compositions comprising such compounds, salts, hydrates and prodrugs, are useful for treating bacterial infections and associated diseases and conditions.

  本文披露了新型桥环双环化合物，以及它们的药用盐、水合物和前药。还披露了包含这些化合物的组合物，制备这些化合物的方法以及将这些化合物用作抗菌剂的方法。所披露的化合物、其药用盐、水合物和前药，以及包含这些化合物、盐、水合物和前药的组合物，可用于治疗细菌感染及相关疾病和症状。
• Thiazole cardiovascular agents
  申请人：Syntex (U.S.A.) Inc.

  公开号：US04064258A1

  公开（公告）日：1977-12-20

  1-Alkylamino-3-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxy)-2-propanol; 5-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxymethylene-N-alkyloxazolid ine and/or 2-substituted oxazolidine derivatives thereof, and methods of making such compounds. The compounds exhibit cardiovascular activity and are useful in the treatment of abnormal heart conditions in mammals. The compounds are also useful in the treatment of hypertension in mammals. The 5-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxymethylene)-N-alkyloxazoli dines and derivatives are also intermediates for the 1-alkylamino-3-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxy)-2-propanol s. The 1-alkylamino-3-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxy)-2-propanol s can be prepared by base or acid hydrolysis of the corresponding 5-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxymethylene)-N-alkyloxazoli dine or derivative; or by treatment of the corresponding 3-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxy)-2,3-epoxypropane with the desired alkylamine. Similarly the 5-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxymethylene)-N-alkyloxazoli dine or derivative can be prepared from the corresponding 1-alkylamino-3-(5-carbocyclicalkylaminocarbonylthiazol-2-yloxy)-2-propanol s via treatment with an aldehyde or ketone.

  1-烷基氨基-3-(5-环烷基氨基甲酰硫唑-2-氧基)-2-丙醇；5-(5-环烷基氨基甲酰硫唑-2-氧甲基-N-烷氧杂环丙烷和/或其2-取代的噁唑烷衍生物，以及制备这种化合物的方法。这些化合物表现出心血管活性，并且在治疗哺乳动物的心脏异常病症方面很有用。这些化合物也在治疗哺乳动物的高血压方面很有用。5-(5-环烷基氨基甲酰硫唑-2-氧甲基)-N-烷氧杂环丙烷和衍生物也是1-烷基氨基-3-(5-环烷基氨基甲酰硫唑-2-氧基)-2-丙醇的中间体。1-烷基氨基-3-(5-环烷基氨基甲酰硫唑-2-氧基)-2-丙醇可以通过对应的5-(5-环烷基氨基甲酰硫唑-2-氧甲基)-N-烷氧杂环丙烷或衍生物的碱或酸水解来制备；或者通过将对应的3-(5-环烷基氨基甲酰硫唑-2-氧基)-2,3-环氧丙烷与所需的烷基胺处理而制备。类似地，5-(5-环烷基氨基甲酰硫唑-2-氧甲基)-N-烷氧杂环丙烷或衍生物可以通过与醛或酮处理来制备，后者来自相应的1-烷基氨基-3-(5-环烷基氨基甲酰硫唑-2-氧基)-2-丙醇。
• ADENOSINE RECEPTOR ANTAGONISTS AND METHODS OF MAKING AND USING THE SAME
  申请人：Ensinger Carol L.

  公开号：US20090221821A1

  公开（公告）日：2009-09-03

  The invention is based on the discovery that compounds of Formula I are unexpectedly highly potent and selective inhibitors of the adenosine A 1 receptor. Adenosine A 1 antagonists can be useful in the prevention and/or treatment of numerous diseases, including cardiac and circulatory disorders, degenerative disorders of the central nervous system, respiratory disorders, and many diseases for which diuretic treatment is suitable. In one embodiment, the invention features a compound of formula I:

  该发明基于发现，公式I化合物是意外地高效和选择性地抑制腺苷A1受体的抑制剂。腺苷A1拮抗剂可用于预防和/或治疗许多疾病，包括心脏和循环系统疾病，中枢神经系统退行性疾病，呼吸系统疾病以及许多适合利尿治疗的疾病。在一种实施例中，该发明涉及公式I的化合物：
• Synthesis, characterization, and chemistry of bridgehead-functionalized bicyclo[2.2.2]octanes: reactions at neopentyl sites
  作者：Kanta Kumar、Shin Shin Wang、Chaim N. Sukenik

  DOI：10.1021/jo00178a018

  日期：1984.2